Self-Injection Market - Trends Forecast Till 2028

Self-Injection Market, By Type (Needle Free Injectors (NFI), Auto Injectors, Pen Injectors, Wearable Injectors), Application (Oncology, Hormonal Disorders, Autoimmune diseases, Orphan Disease, Other Applications), Pattern (Immunizations, Curative Care, Others), Mode of Administration(Skin, Circulatory/ Muskoskeletal, Organs, Central Nervous System), End User(Hospitals and Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical And Biotechnological Companies, Other End User), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-SIM-51

Format:  

Number of Pages: 209

Domain: Healthcare

Self-Injection Market – Trends Forecast Till 2028

The global self-injection market is anticipated to reach USD 9.1 billion by 2020 growing at a CAGR of 11.8% during the forecasting period, 2020-2028. Self-injection is an emerging option for administering drug therapies at home like insulin-dependent diabetics generally adopt self-inject medication as it is an easy and reliable method to self-administer drugs. Factors such as the high prevalence and incidence rate of chronic diseases and the growth of the biologics market are some of the major drivers for the self-injection market

Self-Injection Market – Trends Forecast Till 2028

The global self-injection market is segmented into areas, cancer type, treatment, technology, drugs, stage, end-user, and geography.

Areas segment is segmented into Medical, Surgical, and Radiation. Medical is further segmented into Chemotherapy, Targeted Therapy, and Immunotherapy. Surgical is further segmented into Image-Guided Biopsy, Fine Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Excisional Biopsy, Shave Biopsy, Punch Biopsy, Endoscopic Biopsy, Laparoscopic Biopsy, Bone Marrow Aspiration and Biopsy and Liquid Biopsy.

The cancer type segment is segmented into Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer, and Others

Treatment segment is segmented into Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care and Others

The technology segment is segmented into Car-T Cell Therapy, CRISPR/CAS9, and Others

Drugs segment is segmented into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi, and Others

Stage segment is segmented into Stage I, Stage II, Stage III, and Stage IV

The end-users segment is segmented into Hospitals, Specialty Clinics, Self-injection Centers, Surgical Centers, and Others.

Geographically, the global self-injection market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions 

North America region is the largest contributor to the self-injection market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Key players in the global self-injection market are Elcam Medical, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Inc, Pfizer Inc., Impax Laboratories, Inc., Penjet Corporation, Crossject Needle-Free Injection Systems, Terumo Corporation, Antares Pharma, Becton, Dickinson And Company, Gerresheimer AG, Mylan N.V, Novo Nordisk, Owen Mumford Ltd, Pharmajet, SHL Group, Ypsomed Wilhelm Haselmeier Gmbh & CO. KG, Wilhelm Haselmeier Gmbh & CO. KG and among others among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2019, Baxter has announced the launch of a ready-to-use VANCOMYCIN injection in 0.9% Sodium Chloride in 500 mg, 750 mg, and 1 gram presentation.
  • In 2019, Antares Pharma has announced that the receipt of orphan drug designation to evaluate the use of subcutaneous methotrexate for the treatment of ectopic pregnancy that meets predefined criteria for medical management

Hence, tremendous progress has been made over the last decade and yet a lot more to come in recent years.

Available Customizations

In addition to the market data for the self-injection market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the self-injection market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global self-injection market. Through secondary, the market is classified and segmented as per industry trends, developments, regional markets, products, and technology developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the self-injection market.

The primary respondent breakdown is provided below:

Self-Injection Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the self-injection market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact the primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the self-injection market so as to understand the trends and the factors involved in changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 9.1 billion

Growth Rate

CAGR of 11.8% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year 

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Areas, Cancer Type, Treatment, Technology, Drugs, Stage, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Elcam Medical, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Inc, Pfizer Inc., Impax Laboratories, Inc., Penjet Corporation, Crossject Needle-Free Injection Systems, Terumo Corporation, Antares Pharma, Becton, Dickinson And Company, Gerresheimer AG, Mylan N.V, Novo Nordisk, Owen Mumford Ltd, Pharmajet, SHL Group, Ypsomed Wilhelm Haselmeier Gmbh & CO. KG, Wilhelm Haselmeier Gmbh & CO. KG and among others among others

Available Customization 

In addition to the market data for the self-injection market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements.

 

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.